Medirom Healthcare Technologies (MRM) Non-Current Deffered Revenue (2019 - 2024)
Medirom Healthcare Technologies has reported Non-Current Deffered Revenue over the past 6 years, most recently at $242805.4 for Q4 2024.
- Quarterly results put Non-Current Deffered Revenue at $242805.4 for Q4 2024, down 49.55% from a year ago — trailing twelve months through Dec 2024 was $242805.4 (down 49.55% YoY), and the annual figure for FY2024 was $242805.4, down 49.55%.
- Non-Current Deffered Revenue for Q4 2024 was $242805.4 at Medirom Healthcare Technologies, down from $481238.1 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for MRM hit a ceiling of $3.2 million in Q4 2020 and a floor of $242805.4 in Q4 2024.
- Median Non-Current Deffered Revenue over the past 5 years was $1.1 million (2022), compared with a mean of $1.4 million.
- Biggest five-year swings in Non-Current Deffered Revenue: surged 504.01% in 2020 and later crashed 56.54% in 2023.
- Medirom Healthcare Technologies' Non-Current Deffered Revenue stood at $3.2 million in 2020, then tumbled by 34.2% to $2.1 million in 2021, then plummeted by 47.35% to $1.1 million in 2022, then tumbled by 56.54% to $481238.1 in 2023, then crashed by 49.55% to $242805.4 in 2024.
- The last three reported values for Non-Current Deffered Revenue were $242805.4 (Q4 2024), $481238.1 (Q4 2023), and $1.1 million (Q4 2022) per Business Quant data.